A human multi-lineage hepatic organoid model for liver fibrosis
Por um escritor misterioso
Descrição
Schematic of hiPSCs derived multi‐organoid‐on‐chip system to model
Liver organoids: from basic research to therapeutic applications
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Human liver organoids model progressive inflammatory and fibrotic injury in non-alcoholic fatty liver disease
Frontiers Modeling human liver organ development and diseases with pluripotent stem cell-derived organoids
Liver organoids: an in vitro 3D model for liver cancer study, Cell & Bioscience
Frontiers Liver Organoids: Recent Developments, Limitations and Potential
Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids -on-a-Chip System
IJMS, Free Full-Text
Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Generation of multilineage liver organoids with luminal vasculature and bile ducts from human pluripotent stem cells via modulation of Notch signaling, Stem Cell Research & Therapy
Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases
In vitro functional models for human liver diseases and drug screening: beyond animal testing - Biomaterials Science (RSC Publishing) DOI:10.1039/D1BM01872H
Lineage specification of hFLPCs and formation of liver organoids. (A)